Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Drug Name | HLX20 |
Trade Name | |
Synonyms | HLX 20|HLX-20|Opucolimab |
Drug Descriptions |
HLX20 (Opucolimab) is a monoclonal antibody against CD274 (PD-L1) that inhibits binding to the PDCD1 (PD1) receptor, potentially resulting in enhanced anti-tumor immune response (PMID: 29932513). |
DrugClasses | Immune Checkpoint Inhibitor 147 PD-L1/PD-1 antibody 117 |
CAS Registry Number | 2251771-79-4 |
NCIT ID | C165270 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
HLX20 | HLX20 | 0 | 0 |